Hiroyuki Isayama

Hiroyuki Isayama

Auto-generated profile, based on publicly available information

Hiroyuki Isayama

Department of Gastroenterology Graduate School of Medicine Juntendo University Tokyo Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
MNMasato Nagino
Masato Nagino
SHSatoshi Hirano
Satoshi Hirano
HYHideyuki Yoshitomi
Hideyuki Yoshitomi
TATaku Aoki
Taku Aoki
KUKatsuhiko Uesaka
Katsuhiko Uesaka
IEItaru Endo
Itaru Endo

7 January 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
PDF file
Sohei SatoiSohei Satoi
Sohei Satoi
NTNaminatsu Takahara
Naminatsu Takahara
Tsutomu FujiiTsutomu Fujii
Tsutomu Fujii
HIHiroyuki Isayama
Hiroyuki Isayama
SYSuguru Yamada
Suguru Yamada
JKJoji Kitayama
Joji Kitayama
Patients with pancreatic ductal adenocarcinoma (PDAC) with peritoneal dissemination have a dismal prognosis because discontinuation of systemic chemotherapy is required for massive ascites or poor performance status. The natural history, diagnosis and treatment of PDAC with peritoneal dissemination have not been fully investigated. We systematically reviewed published information on the clinical diagnosis and treatment of PDAC with peritoneal dissemination using the PubMed database (2000‐2020) and provided recommendations in response to clinical questions. This guideline was created according to the "Minds Clinical Practice Guideline Development Guide 2017". The literature quality and body of evidence were evaluated with the GRADE System and classified into four levels (“strong”, “medium”, “weak”, “very weak”). The strength of each final recommendation was decided by a vote of committee members based on the GRADE Grid method. These guidelines address three subjects: diagnostic, chemotherapeutic, and surgical approaches. They include nine clinical questions and statements with recommendation strengths, evidence levels, and agreement rates, in addition to one “column”. This is the English synopsis of the 2021 Japanese clinical practice guideline for PDAC with peritoneal dissemination. It summarizes the clinical evidence for the diagnosis and treatment of PDAC with peritoneal dissemination and provides future perspectives.

16 March 2025 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
HKHiroyuki Kato
Hiroyuki Kato
AHAkihiko Horiguchi
Akihiko Horiguchi
TOTakao Ohtsuka
Takao Ohtsuka
ANAtsushi Nanashima
Atsushi Nanashima
MUMichiaki Unno
Michiaki Unno
IEItaru Endo
Itaru Endo